Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8410051 FGF21 mutants and uses thereof

Patent 8410051 was granted and assigned to Amgen on April, 2013 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Yue-Sheng Li0

Mark Leo Michaels0

Murielle Marie Ellison0

Randy Ira Hecht0

Agnes Eva Hamburger0

Edward John Belouski0

Jeonghoon Sun0

Jing Xu0

Date of Patent

April 2, 2013

0

Patent Application Number

131965440

Date Filed

August 2, 2011

0

Patent Citations Received

US Patent 11993637 Modified FGF-21 polypeptides with non-naturally encoded amino acids

0

US Patent 11667708 Anti-human beta klotho antibody or binding fragment thereof and methods of their use

0

US Patent 11746134 Human FGF21 mutant with improved effectiveness and stability and pharmaceutical composition thereof

Patent Primary Examiner

Christine J. Saoud

0

Patent abstract

The invention provides nucleic acid molecules encoding FGF21 mutant polypeptides, FGF21 mutant polypeptides, pharmaceutical compositions comprising FGF21 mutant polypeptides, and methods for treating metabolic disorders using such nucleic acids, polypeptides, or pharmaceutical compositions.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8410051 FGF21 mutants and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool